A contemporary review on the genetic basis of atrial fibrillation

Jason D Roberts1, Michael H Gollob1

  • 1University of Ottawa Heart Institute, Ottawa, Ontario.

Insights

Atrial fibrillation (AF) is a common heart rhythm disorder with significant health risks. Understanding its genetic basis and patient heterogeneity is key to developing more effective treatments.

Area of Science:

  • Cardiology
  • Genetics
  • Pharmacology

Background:

  • Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia, leading to increased risks of heart failure, stroke, and mortality.
  • Current AF treatments have limited efficacy, potentially due to a poor understanding of its complex pathophysiology and significant interindividual variability.
  • Epidemiological and genetic studies confirm a substantial heritable component to AF, highlighting genetic factors in its diverse manifestations.

Purpose of the Study:

  • To explore the genetic underpinnings of atrial fibrillation (AF).
  • To investigate the heterogeneity in AF pathophysiology.
  • To propose a genotype-guided approach for improved AF management.

Main Methods:

  • Review of epidemiological studies on AF heritability.
  • Analysis of genetic investigations into AF.
  • Conceptual framework for subdividing AF based on genotype.

Main Results:

  • AF exhibits considerable interindividual variability in pathophysiology, influenced by genetic factors.
  • This heterogeneity likely contributes to the modest efficacy of current AF therapies.
  • Subtyping AF by genetic mechanisms offers a potential pathway to personalized treatment.

Conclusions:

  • Recognizing the genetic heterogeneity of atrial fibrillation is crucial for advancing treatment strategies.
  • A pharmacogenetic approach, tailoring treatments based on an individual's genetic profile, holds promise for significantly improving AF management and patient outcomes.

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.1K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
137
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
157
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.4K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K